spacer
home > pmps > winter 2019 > supply forecast
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Supply Forecast

Packaging any pharmaceutical product can be a complex process. Ensuring a drug is packaged in compliance with the marketing authorisation and in a manner appropriate to environmental conditions requires detailed knowledge and experience, as well as having sufficiently trained staff and suitable facilities. This challenge is even greater if multiple drugs are being packaged for multiple markets at a single manufacturing site.

However, packaging products for clinical trials is arguably the most complicated and high-risk type of packaging work carried out in the pharma industry. The additional complexity introduced when there are numerous clinical sites means a detailed understanding of the regulations covering trials, as well as comprehensive knowledge of the study design and clinical protocol, is absolutely essential.

Various considerations in relation to packaging clinical supply will be discussed in this article, including the challenges associated with blinding supply and the impact that looming deadlines, such as that of serialisation, could have on the timescales and the overall cost of clinical trials. Overcoming these complexities through the introduction of new practices, such as just-in-time labelling, will also be outlined.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Colin Newbould is Director of Regulatory Affairs and QP Services at Wasdell Group. He is also one of Wasdell’s QPs for certification to the European market. Colin has over 20 years’ experience in the pharma industry, and, having previously held management positions at PCI Pharma Services, Penn Pharmaceutical Services, and Catalent, Colin also has expertise in facility design and start-up, high potent manufacturing, managing supply chain quality, risk management, and continuous improvement. He holds a BSc in chemistry with analytical chemistry and toxicology, is a current management committee member of the Pharmaceutical and Healthcare Sciences Society, and has previous terms with the Pharmaceutical Quality Group.
spacer
Colin Newbould
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Genome & Company Chooses Luina Bio to Supply Innovative Drug Productfor Clinical Trials Programme

Luina Bio, a leading biopharmaceutical manufacturing company in Australia, today announced it will develop and produce an innovative bacterial drug product for Genome & Company to support its clinical trials programme. The relationship signals Luina Bio’s first foray into Asia and further establishes its global leadership in the current Good Manufacturing Practise for microbiome projects.
More info >>

White Papers
 
Industry Events

Clinical Trial Supply Europe 2019

13-14 March 2019, Milan, Italy

Following on from our largest and most engaging meeting to date, Clinical Trial Supply Europe will be returning to Milan for its 20th year in 2019! The 19th annual edition welcomed pharmaceutical companies across Europe who got together to share knowledge and issues regarding clinical trial supplies, both with regards to operational and technological challenges. Over the two days, delegates discussed issues which affected their business in our dedicated operational and technological streams.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement